聚合物纳米粒子的最新进展:癌症治疗中的当前策略和翻译挑战
Kumar Janakiraman1, Vaidevi Sethuraman1, Venkateshwaran Krishnaswami2
1Department of Biotechnology, Rathinam Technical Campus, Coimbatore, India.
Journal of chemotherapy (Florence, Italy)
|November 1, 2025
概括
基于聚合物的纳米粒子 (PNPs) 增强了癌症药物输送,改善了溶解性和瘤向性. 这些先进的纳米载体显示出显著的潜力,以提高治疗效率和患者在瘤学的结果.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 基于聚合物的纳米粒子 (PNPs) 在癌症治疗中至关重要,改善药物溶解性,药理动力学和瘤向.
- 纳米粒子提供了增强的表面积,可控释放和封装各种治疗化合物.
- PNP增加了抗癌药物的生物可用性和有效性,具有高的药物加载效率 (80-90%).
研究的目的:
- 审查用于癌症治疗的聚合物纳米载体的进展.
- 巩固纳米球,纳米囊和混合复合材料的进展.
- 为应对监管批准和个性化瘤整合方面的挑战.
主要方法:
- 在癌症治疗中对聚合物基纳米颗粒的最新研究的文献综述.
- 对纳米粒子特征的分析,包括药物负载,循环半衰期和瘤积累.
- 对FDA批准和临床阶段PNP配方的检查.
主要成果:
- 与免费药物相比,PNP显示出2-5倍的循环半衰期延长和3-10倍的瘤积累.
- 高药物加载效率 (80-90%) 可以通过PNP实现.
- 经批准的配方如Abraxane®和临床候选物如Genexol-PM®强调了PNP的翻译相关性.
结论:
- 基于聚合物的纳米粒子代表了癌症治疗的重大进步.
- 在临床瘤学中,PNP具有巨大的潜力,可以提高治疗效率和患者的治疗结果.
- 需要进一步的研究来克服监管障碍,并将PNP整合到个性化瘤学中.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


